Analysis of nonalcoholic steatohepatitis and the risk of cardiovascular event in terms of lipid metabolism abnormality

Analysis of nonalcoholic steatohepatitis and the risk of cardiovascular event in terms of lipid metabolism abnormality - Analysis of nonalcoholic steatohepatitis and the risk of cardiovascular event

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009614

Enrollment

100

Registered

2012-12-25

Start date

2012-12-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic fatty liver disease

Interventions

control lipid-lowering drug

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with NAFLD diagnosed by liver biopsy

Exclusion criteria

Exclusion criteria: Subjects with a history of excessive alcohol consumption (>140 g/week for men, >70 g/week for women), other liver diseases, drug use associated with fatty liver, or weight reduction were excluded

Design outcomes

Primary

Measure	Time frame
Small dense LDL cholesterol and non-HDL cholesterol	—

Countries

Japan

Contacts

Public ContactKento Imajo

Yokohama City University Graduate School of Medicine Division of Gastroenterology

kento318@yokohama-cu.ac.jp045-787-2640

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026